by Lactulose is a synthetic disaccharide used as a laxative and treatment for constipation and hepatic encephalopathy. It works by drawing water into the colon from surrounding tissues which softens and increases the bulk of stool, thereby stimulating bowel movements. Lactulose is commonly available as an oral liquid solution and is prescribed for both short-term and long-term treatment of constipation in adults and children. The growing prevalence of irritable bowel syndrome (IBS) and constipation, along with the expansion of therapeutic applications of lactulose beyond constipation are the major factors fueling the demand for lactulose.
The Global Lactulose Market Size is estimated to be valued at US$ 201.94 Bn in 2024 and is expected to exhibit a CAGR of 13. % over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Lactulose market are Amgen Inc., F. Hoffmann-La Roche AG., Intas Pharmaceuticals Ltd., AstraZeneca plc, Mylan N.V., Dr. Reddy’s Laboratories, Bristol – Myers Squibb, Merck & Co., Inc., BIOCAD-Biotechnology company, Reliance Life Sciences, Biocon Limited, and Hetero Drugs Limited. The major players are investing in R&D activities to develop advanced lactulose products with improved efficacy and safety.
The rising geriatric population suffering from chronic constipation and growing awareness about lactulose therapy present significant growth opportunities for players in the market. Furthermore, lactulose manufacturers are focusing on geographic and application expansions to untapped emerging markets in Asia Pacific and Latin America.
The increasing global burden of constipation, diarrhea, and hepatic encephalopathy coupled with growing adoptions of lactulose therapy over other laxatives is facilitating the global expansion of the lactulose market. The market is witnessing increased adoption in countries such as India, China, Brazil owing to rising healthcare expenditures and large patient pools in these countries.
Market Drivers
The rising prevalence of gastrointestinal disorders such as chronic idiopathic constipation, irritable bowel syndrome, and diverticular disease are the key factors driving the demand for lactulose. According to a study published in the American Journal of Gastroenterology, constipation affects approximately 2 million people annually in the United States. Additionally, expanding therapeutic applications of lactulose such as in treatment of hepatic encephalopathy is further fueling market growth.
PEST Analysis
Political: The lactulose market is subject to regulations regarding food and drug safety set by regulatory bodies. Changes in regulations may impact the production, packaging, advertising, distribution and sale of lactulose products.
Economic: Changes in economic conditions can affect consumer spending patterns and therefore demand for lactulose products. The overall economic growth outlook also determines the investment in the healthcare sector.
Social: Lactulose is used for the treatment of constipation. Population ageing and growing health awareness positively influence the demand for treatment of gastrointestinal disorders treated by lactulose.
Technological: Advancements in crystalline and spray-dried technology have enabled manufacturers to produce high purity lactulose with improved taste and solubility. Further research is being conducted on developing novel delivery methods.
Geographical Regions with High Market Concentration
The lactulose market in terms of value is highly concentrated in North America and Europe. This can be attributed to well-established healthcare infrastructure and wider acceptance of lactulose for various chronic conditions in these regions. According to some estimates, Europe accounted for over 30% of the global market share in 2024.
Fastest Growing Region
The Asia Pacific region is poised to be the fastest growing market for lactulose during the forecast period. This is driven by factors like rising healthcare expenditure, growing geriatric population, increasing middle class, and rapid urbanization in countries like China, India and Japan. Government initiatives to improve access to healthcare are also supporting market growth in Asia Pacific.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
